Skip to main content
Contact Us
Subscribe
E-Edition
40°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cidara Thera
(NQ:
CDTX
)
0.7800
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 5, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cidara Thera
< Previous
1
2
3
4
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
March 23, 2023
We're starting off the day with a look at the biggest pre-market stock movers traders need to know about on Thursday morning!
Via
InvestorPlace
Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 03, 2023
Gainers ObsEva SA (NASDAQ: OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.
Via
Benzinga
Looking Into Cidara Therapeutics's Return On Capital Employed
November 25, 2022
Via
Benzinga
Cidara's Lead Antifungal Candidate Goes Under Priority FDA Review
September 21, 2022
Via
Benzinga
Recap: Cidara Therapeutics Q2 Earnings
August 09, 2022
Cidara Therapeutics (NASDAQ:CDTX) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Heritage Insurance Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
March 03, 2023
Gainers ObsEva SA (NASDAQ: OBSV) rose 93.1% to $0.2047 in pre-market trading after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 03, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
March 03, 2023
We're starting off Friday morning with a breakdown of the biggest pre-market stock movers traders need to keep an eye on!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
March 02, 2023
Via
Benzinga
With FDA Submission, Cidara Therapeutics Inks US Pact For Bloodstream Infection Candidate
July 27, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 01, 2023
Via
Benzinga
Johnson & Johnson-Backed Antiviral Candidate Effectively Prevents Influenza Infection
March 01, 2023
Cidara Therapeutics Inc (NASDAQ: CDTX) announced efficacy and safety data from a planned interim analysis of the ongoing Phase 2a trial evaluating the pre-exposure prophylactic activity of CD388...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 25, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 24, 2023
Via
Benzinga
Why FARO Technologies Shares Are Trading Lower By 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 20, 2023
Gainers Helbiz, Inc. (NASDAQ: HLBZ) shares jumped 133.1% to $0.2870. Helbiz recently announced discontinuation of operations in non-profitable markets.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 20, 2023
Via
Benzinga
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
December 27, 2022
Biopharma stocks were not immune to the broader market downturn seen for much of 2022.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 07, 2022
Gainers Cidara Therapeutics (NASDAQ:CDTX) shares rose 14.6% to $0.64 during Monday's pre-market session. The market value of their outstanding shares is at $44.9 million. The company's, Q3 earnings...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 10, 2022
Gainers NeuroMetrix (NASDAQ:NURO) shares increased by 23.0% to $3.48 during Monday's pre-market session. The company's market cap stands at $24.8 million.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 20, 2022
Gainers CinCor Pharma (NASDAQ:CINC) shares moved upwards by 19.5% to $33.0 during Tuesday's after-market session. The market value of their outstanding shares is at $1.4 billion.
Via
Benzinga
Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary
September 13, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 07, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 17, 2022
Via
Benzinga
Short Volatility Alert: Cidara Therapeutics, Inc.
August 05, 2022
On Thursday, shares of Cidara Therapeutics, Inc. (NASDAQ: CDTX) experienced volatile short activity. After the activity, the stock price went down -3.74% to $0.72. The overall sentiment for CDTX has...
Via
Benzinga
Short Volatility Alert: Cidara Therapeutics, Inc.
August 01, 2022
On Friday, shares of Cidara Therapeutics, Inc. (NASDAQ: CDTX) experienced volatile short activity. After the activity, the stock price went up +7.53% to $0.785. The overall sentiment for CDTX has been...
Via
Benzinga
Recap of Wednesday's Biotech Catalysts - End of The Day Summary
July 27, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
July 27, 2022
Via
Benzinga
Cidara Pursues FDA Approval For Bloodstream Infections Candidate
July 27, 2022
Cidara Therapeutics, Inc. (NASDAQ: CDTX) has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its lead asset Rrezafungin for the treatment of candidemia and...
Via
Benzinga
Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy
July 27, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 27, 2022
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.